Snowball logo
logo
GUAR_logo

Guard Therapeutics International AB

GUARD ST
SEK 1.292-SEK 0.036  (2.71%)
Estimate
EPS
-3.57
Beta
-0.177
Growth
Net income, YoY
81.44%
FCF, YoY
75.22%
Forecast
P/E (FWD)
0.5
EPS (FWD)
2.6
About the company
Ticker
GUARD
ISIN
SE0009973357
Country
Sweden
Sector (GICS)
Healthcare
Disruptive Pharma Holding Ab (Publ) operates as a pharmaceutical technology company that develops and commercializes patented platform technology for the formulation and development of pharmaceutical products. The company was incorporated in 2021 and is based in Uppsala, Sweden.

Frequently asked questions

What sector does Guard Therapeutics International AB (GUARD) operate in?

Guard Therapeutics International AB belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Guard Therapeutics International AB (GUARD) current stock price?

As of the latest data, Guard Therapeutics International AB stock price is SEK 1.29, with a previous close of SEK 1.33. Guard Therapeutics International AB lost -SEK 0.04 in the last trading session, representing a -2.71% loss.

What is Guard Therapeutics International AB (GUARD) current market capitalization?

Guard Therapeutics International AB market cap is approximately 26.06 million.

What is Guard Therapeutics International AB (GUARD) Earnings Per Share (EPS)?

The trailing EPS is -SEK 3.57, and the forward EPS is SEK 2.60.

What is Guard Therapeutics International AB (GUARD) EBITDA?

Guard Therapeutics International AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -6.56 million.

Does Guard Therapeutics International AB (GUARD) pay dividends?

No. Guard Therapeutics International AB does not pay a dividend.

What is Guard Therapeutics International AB (GUARD) beta (volatility) score?

Guard Therapeutics International AB has a beta of -0.177, indicating lower volatility than the overall market.